Dr Jacqui Schiesser
Dr Jacqui Schiesser
Details
Role
Team Leader / Senior Research Officer
Research area
Stem Cell Medicine
Group
Immune Development
Contact
Available for student supervision
Jacqui Schiesser is a Senior Research Officer in the Immune Development group at the Murdoch Children’s Research Institute (MCRI).
She completed her PhD in 2013 studying human stem cell differentiation and pancreatic development. Following this, she undertook postdoctoral studies in the laboratory of James Wells at Cincinnati Children’s Hospital Medical Center.
Her current research focuses on the utilisation of stem cell models of type 1 diabetes and identification of cell-surface markers for the quantitative analysis of human islet cellular composition.
She completed her PhD in 2013 studying human stem cell differentiation and pancreatic development. Following this, she undertook postdoctoral studies in the laboratory of James Wells at Cincinnati Children’s Hospital Medical Center.
Her current research focuses on the utilisation of stem cell models of type 1 diabetes and identification of cell-surface markers for the quantitative analysis of human islet cellular composition.
Jacqui Schiesser is a Senior Research Officer in the Immune Development group at the Murdoch Children’s Research Institute (MCRI).
She completed her PhD in 2013 studying human stem cell differentiation and pancreatic development. Following this,...
She completed her PhD in 2013 studying human stem cell differentiation and pancreatic development. Following this,...
Jacqui Schiesser is a Senior Research Officer in the Immune Development group at the Murdoch Children’s Research Institute (MCRI).
She completed her PhD in 2013 studying human stem cell differentiation and pancreatic development. Following this, she undertook postdoctoral studies in the laboratory of James Wells at Cincinnati Children’s Hospital Medical Center.
Her current research focuses on the utilisation of stem cell models of type 1 diabetes and identification of cell-surface markers for the quantitative analysis of human islet cellular composition.
She completed her PhD in 2013 studying human stem cell differentiation and pancreatic development. Following this, she undertook postdoctoral studies in the laboratory of James Wells at Cincinnati Children’s Hospital Medical Center.
Her current research focuses on the utilisation of stem cell models of type 1 diabetes and identification of cell-surface markers for the quantitative analysis of human islet cellular composition.
Top Publications
- Schiesser, JV, Yu, Y, Loudovaris, T, Thomas, HE, Elefanty, AG, Stanley, EG. LY6H is a marker of human pancreatic delta cells.. Sci Rep 15(1) : 33011 2025 view publication
- Schiesser, J, Elliott, M, Adenwalla, N, Loudovaris, T, Stanley, E. 12-6: DEVELOPMENT OF A HIGH-DIMENSIONAL FLOW CYTOMETRY ASSAY TO ASSESS ISLET COMPOSITION. Transplantation 109(6S1) : 56 -56 2025 view publication
- Sun, S, Motazedian, A, Li, JY, Wijanarko, K, Zhu, JJ, Tharmarajah, K, Strumila, KA, Shkaruta, A, Nigos, LR, Schiesser, JV, et al. Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis.. Nat Commun 15(1) : 7698 2024 view publication
- Schiesser, JV, Yu, Y, Loudovaris, T, Thomas, HE, Elefanty, AG, Stanley, EG. 336.3: Identification of novel cell surface markers for the characterization of human beta cell replacement therapies. Transplantation 107(10S2) : 135 -135 2023 view publication
- Labonne, T, Elefanty, AG, Stanley, EG, Schiesser, JV. An INSULIN-GFP/GLUCAGON-mCherry reporter line for the study of human pancreatic endocrine cell development.. Stem Cell Res 56: 102547 2021 view publication
Page 1 of 5
Career information
Share //
